Erschienen in:
20.05.2019 | Editorial
The quest to improve sudden cardiac death prediction using sympathetic innervation scintigraphy: Chasing a mirage?
verfasst von:
Firas J. Al Badarin, MD, Poghni Peri-Okonny, MD MSc
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 3/2020
Einloggen, um Zugang zu erhalten
Excerpt
Treatment options for patients with congestive heart failure (CHF) have evolved substantially over the last two decades to currently include various pharmaceutical and device-based therapies that improve clinical outcomes and quality of life in this population. For example, implantable cardiac defibrillators (ICDs) are now the cornerstone of primary prevention of sudden cardiac death (SCD) in patients with reduced left ventricular ejection fraction (LVEF),
1 supported by significant improvement in overall survival in device recipients.
2 …